X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13812) 13812
Newsletter (47) 47
Magazine Article (41) 41
Book Chapter (39) 39
Publication (6) 6
Dissertation (2) 2
Web Resource (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12459) 12459
azathioprine - therapeutic use (10045) 10045
female (6995) 6995
male (6611) 6611
adult (5617) 5617
immunosuppressive agents - therapeutic use (5503) 5503
middle aged (4416) 4416
azathioprine (4343) 4343
index medicus (3207) 3207
prednisone - therapeutic use (2646) 2646
drug therapy, combination (2606) 2606
adolescent (2267) 2267
aged (2027) 2027
transplantation (1918) 1918
surgery (1886) 1886
treatment outcome (1882) 1882
gastroenterology & hepatology (1877) 1877
cyclosporine - therapeutic use (1782) 1782
azathioprine - adverse effects (1627) 1627
child (1612) 1612
kidney transplantation (1608) 1608
immunology (1544) 1544
prednisolone - therapeutic use (1544) 1544
follow-up studies (1502) 1502
time factors (1494) 1494
retrospective studies (1431) 1431
immunosuppressive agents - adverse effects (1429) 1429
therapy (1386) 1386
cyclophosphamide - therapeutic use (1369) 1369
immunosuppression (1329) 1329
azathioprine - administration & dosage (1209) 1209
adrenal cortex hormones - therapeutic use (1187) 1187
crohn disease - drug therapy (1132) 1132
transplantation, homologous (1048) 1048
animals (1015) 1015
inflammatory-bowel-disease (984) 984
kidney transplantation - immunology (943) 943
infliximab (911) 911
6-mercaptopurine (840) 840
methotrexate - therapeutic use (835) 835
glucocorticoids - therapeutic use (819) 819
immunosuppressive agents - administration & dosage (818) 818
mycophenolic acid - therapeutic use (807) 807
mercaptopurine - therapeutic use (806) 806
crohn's disease (792) 792
pharmacology & pharmacy (787) 787
cyclosporine (774) 774
cyclosporins - therapeutic use (762) 762
medicine, general & internal (761) 761
mycophenolic acid - analogs & derivatives (747) 747
methylprednisolone - therapeutic use (745) 745
anti-inflammatory agents - therapeutic use (739) 739
crohns-disease (723) 723
rheumatology (722) 722
prognosis (716) 716
inflammatory bowel disease (704) 704
child, preschool (696) 696
recurrence (690) 690
risk factors (684) 684
colitis, ulcerative - drug therapy (683) 683
antibodies, monoclonal - therapeutic use (682) 682
antilymphocyte serum - therapeutic use (667) 667
biopsy (654) 654
prospective studies (650) 650
methotrexate (646) 646
young adult (622) 622
graft rejection (602) 602
inflammatory bowel diseases - drug therapy (597) 597
chronic disease (558) 558
care and treatment (556) 556
ulcerative colitis (536) 536
corticosteroids (535) 535
clinical trials as topic (532) 532
remission induction (525) 525
cyclophosphamide (510) 510
immunosuppressive agents (491) 491
double-blind (465) 465
lupus erythematosus, systemic - drug therapy (457) 457
creatinine - blood (450) 450
mycophenolate-mofetil (450) 450
disease (448) 448
drug therapy (446) 446
arthritis, rheumatoid - drug therapy (445) 445
remission (441) 441
graft survival (434) 434
graft rejection - prevention & control (424) 424
management (420) 420
medicine & public health (417) 417
kidney transplantation - physiology (416) 416
patients (410) 410
tacrolimus - therapeutic use (410) 410
efficacy (397) 397
children (380) 380
diagnosis (371) 371
mycophenolate mofetil (354) 354
drug administration schedule (348) 348
diagnosis, differential (343) 343
severity of illness index (342) 342
dermatology (332) 332
dose-response relationship, drug (332) 332
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11937) 11937
German (821) 821
French (363) 363
Spanish (183) 183
Italian (147) 147
Russian (119) 119
Japanese (99) 99
Polish (84) 84
Hungarian (30) 30
Dutch (28) 28
Portuguese (27) 27
Romanian (27) 27
Korean (23) 23
Danish (22) 22
Czech (19) 19
Chinese (13) 13
Norwegian (13) 13
Swedish (12) 12
Bulgarian (11) 11
Croatian (11) 11
Finnish (10) 10
Hebrew (7) 7
Serbian (6) 6
Slovak (5) 5
Lithuanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2016, Volume 2016, Issue 10, p. CD003594
Journal Article
Medical Clinics of North America, ISSN 0025-7125, 05/2012, Volume 96, Issue 3, pp. 475 - 496
Over the past several decades, rheumatology has directed its focus to understanding and countering the immune dysregulation underlying autoimmune diseases with... 
Biologic response modifiers | Systemic lupus erythematosus | Vasculitis | Disease-modifying antirheumatic drugs | Biologics | Rheumatoid arthritis | SYSTEMIC-LUPUS-ERYTHEMATOSUS | RITUXIMAB THERAPY | 5-AMINOSALICYLIC ACID | REFRACTORY NEUROSARCOIDOSIS | ADENOSINE RECEPTORS | MEDICINE, GENERAL & INTERNAL | TUMOR-NECROSIS-FACTOR | COMBINATION TREATMENT | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | MYCOPHENOLATE-MOFETIL | Hydroxychloroquine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Certolizumab Pegol | Rheumatic Diseases - drug therapy | Colchicine - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Immunoglobulin Fab Fragments - therapeutic use | Methotrexate - therapeutic use | Polyethylene Glycols - therapeutic use | Cyclophosphamide - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Abatacept | Etanercept | Infliximab | Minocycline - therapeutic use | Immunoconjugates - therapeutic use | Antirheumatic Agents - therapeutic use | Rheumatic Diseases - immunology | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Immunoglobulin G - therapeutic use | Rituximab | Cyclosporine - therapeutic use | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Isoxazoles - therapeutic use | Adalimumab | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Tumor Necrosis Factors - antagonists & inhibitors
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2017, Volume 2019, Issue 10, p. CD003280
Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a disease that causes progressive or relapsing and remitting weakness and... 
Immunologic Factors | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Chronic inflammatory demyelinating polyradiculopathy | Immunosuppressive Agents | Chronic inflammatory demyelinating polyradiculoneuropathy | Interferon beta‐1a | Treatment Outcome | Immunosuppressive and immunomodulatory treatment | Randomized Controlled Trials as Topic | Neurology | Interferon‐beta | Anti‐Inflammatory Agents | Azathioprine | Methotrexate | Medicine General & Introductory Medical Sciences | Immunoglobulins, Intravenous | Peripheral Neuropathy | SYSTEMIC-LUPUS-ERYTHEMATOSUS | Interferon-beta [therapeutic use] | Immunologic Factors [therapeutic use] | Humans | GUILLAIN-BARRE-SYNDROME | Immunosuppressive Agents [therapeutic use] | Anti-Inflammatory Agents [therapeutic use] | Azathioprine [therapeutic use] | RANDOMIZED CONTROLLED TRIAL | DISEASE-MODIFYING THERAPY | MEDICINE, GENERAL & INTERNAL | Interferon beta-1a | HIGH-DOSE CYCLOPHOSPHAMIDE | INTRAVENOUS IMMUNOGLOBULIN | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating [drug therapy] | TERM-FOLLOW-UP | PLACEBO-CONTROLLED TRIAL | STEM-CELL TRANSPLANTATION | Methotrexate [therapeutic use] | MYCOPHENOLATE-MOFETIL | Interferon-beta - therapeutic use | Azathioprine - therapeutic use | Interferon beta-1a - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Immunosuppressive Agents - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy | Anti-Inflammatory Agents - therapeutic use | Methotrexate - therapeutic use | Immunologic Factors - therapeutic use
Journal Article
Medical Clinics of North America, ISSN 0025-7125, 05/2012, Volume 96, Issue 3, pp. 621 - 634
Type 1 diabetes is an autoimmune disease that gradually destructs insulin-producing beta cells. Over the years, clinicians' knowledge regarding the... 
Immunosuppressants | Transplantation | Diabetes mellitus type 1 | Immunomodulators | Immunotherapies | NOD MICE | ANTI-CD3 MONOCLONAL-ANTIBODY | RANDOMIZED CONTROLLED-TRIAL | BETA-CELL FUNCTION | PROTEIN PEPTIDE DIAPEP277 | MEDICINE, GENERAL & INTERNAL | ISLET GRAFT-SURVIVAL | PHASE-II TRIAL | RECENT-ONSET | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Azathioprine - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Insulin - immunology | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Fatty Acids, Unsaturated - therapeutic use | Pyrazines - therapeutic use | Secondary Prevention | Diabetes Mellitus, Type 1 - therapy | Receptors, Tumor Necrosis Factor - therapeutic use | Abatacept | Etanercept | Glutamate Decarboxylase - therapeutic use | Antilymphocyte Serum - therapeutic use | Immunoconjugates - therapeutic use | Islets of Langerhans Transplantation | Diabetes Mellitus, Type 1 - immunology | Sitagliptin Phosphate | Tertiary Prevention | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Primary Prevention | Antibodies, Monoclonal, Humanized - therapeutic use | Interferon-alpha - therapeutic use | Immunoglobulin G - therapeutic use | Niacinamide - therapeutic use | Rituximab | Vitamins - therapeutic use | Cyclosporine - therapeutic use | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Diet | Venoms - therapeutic use | Peptide Fragments - therapeutic use | Vitamin D - therapeutic use | Chaperonin 60 - therapeutic use | Insulin - therapeutic use | Peptides - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Hypoglycemic Agents - immunology
Journal Article
2005, Volume 6, Issue 2, 11
.... Since there are almost no randomized, controlled, double-blind studies comparing the use of various therapeutic agents in this condition, treatment decisions still rely heavily on individual clinicians experience... 
Methotrexate, therapeutic use | Mitomycin, therapeutic use | Tetracyclines, therapeutic use | Sulfasalazine, therapeutic use | Tacrolimus, therapeutic use | Nicotinamide, therapeutic use | Cyclophosphamide, therapeutic use | Mycophenolate mofetil, therapeutic use | Pemphigoid, treatment | Calcineurin inhibitors, therapeutic use | Azathioprine, therapeutic use | Leflunomide, therapeutic use | Immunoglobulins, therapeutic use | Interferon alpha 2b, therapeutic use | Corticosteroids, therapeutic use | Sulfapyridine, therapeutic use | Sulfamethoxypyridazine, therapeutic use | Thalidomide, therapeutic use | Ciclosporin, therapeutic use | Prednisone, therapeutic use | Pharmacotherapy | Medicine & Public Health | Pharmacology/Toxicology | Dermatology | PLASMA-EXCHANGE | IMMUNOSUPPRESSIVE THERAPY | TOPICAL CYCLOSPORINE | MITOMYCIN-C | PASSIVE TRANSFER | INTRAVENOUS IMMUNOGLOBULIN THERAPY | SYSTEMIC CHEMOTHERAPY | THALIDOMIDE THERAPY | NECROSIS-FACTOR-ALPHA | MYCOPHENOLATE-MOFETIL | DERMATOLOGY | Calcineurin Inhibitors | Pemphigoid, Benign Mucous Membrane - therapy | Antibiotics, Antineoplastic - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Mitomycin - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Administration, Topical | Tetracyclines - therapeutic use | Plasmapheresis
Book Review
Chest, ISSN 0012-3692, 03/2016, Volume 149, Issue 3, pp. 756 - 766
Journal Article
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 6, p. e0198184
... of splenectomy (Splx) as the first and still successfully used therapeutic measure in management of immune thrombocytopenia (ITP) [1]. The second therapeutic measure... 
AUTOIMMUNE THROMBOCYTOPENIA | TREATMENT OPTIONS | ADULT PATIENTS | INTRAVENOUS GAMMA-GLOBULIN | MANAGEMENT | ANTI-D | MEDICAL THERAPY | SAFETY | PURPURA | ROMIPLOSTIM | MULTIDISCIPLINARY SCIENCES | Prednisolone - adverse effects | Azathioprine - therapeutic use | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Dapsone - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Young Adult | Aged, 80 and over | Child | Rituximab - adverse effects | Purpura, Thrombocytopenic, Idiopathic - surgery | Combined Modality Therapy | Remission Induction | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Rho(D) Immune Globulin - adverse effects | Cyclosporine - adverse effects | Adolescent | Rho(D) Immune Globulin - therapeutic use | Dapsone - adverse effects | Benzoates - adverse effects | Recombinant Fusion Proteins - therapeutic use | Thrombopoietin - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - therapy | Rituximab - therapeutic use | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Resistance | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Treatment Outcome | Thrombopoietin - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Hydrazines - adverse effects | Thrombocytopenic purpura | Clinical trials | Treatment outcome | Care and treatment | Analysis | Drugs | Thrombocytopenia | Therapy | Immunoglobulins | Dexamethasone | Intravenous administration | Medical treatment | Patients | Immunosuppressive agents | Bleeding | Medicine | Remission | Clinical medicine | Azathioprine | Drug dosages | Prednisolone
Journal Article
Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 6, pp. CD002922 - CD002922
Background Cyclophosphamide, in combination with corticosteroids, has been first‐line treatment for inducing disease remission for proliferative lupus... 
Kidney disease | Glomerular diseases | Recurrence | Immunosuppressive Agents | Glucocorticoids | Calcineurin | Induction Chemotherapy | Chronic kidney disease | Mycophenolic Acid | Randomized Controlled Trials as Topic | Cyclophosphamide | Tacrolimus | Lupus Nephritis | Child health | Glomerular disease | Maintenance Chemotherapy | Azathioprine | Medicine General & Introductory Medical Sciences | LONG-TERM | PULSE INTRAVENOUS CYCLOPHOSPHAMIDE | Induction Chemotherapy [methods] | Mycophenolic Acid [ analogs & derivatives; therapeutic use] | Cyclophosphamide [ therapeutic use] | Humans | ORAL MYCOPHENOLATE-MOFETIL | Lupus Nephritis [ drug therapy] | RANDOMIZED CONTROLLED-TRIAL | CHRONIC PLASMA-EXCHANGE | Azathioprine [therapeutic use] | MAINTENANCE THERAPY | MEDICINE, GENERAL & INTERNAL | Glucocorticoids [therapeutic use] | Immunosuppressive Agents [ therapeutic use] | Maintenance Chemotherapy [methods] | INDUCTION THERAPY | Adult | TERM-FOLLOW-UP | QUALITY-OF-LIFE | Child | STAGE RENAL-DISEASE | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Immunosuppressive Agents - therapeutic use | Induction Chemotherapy - methods | Lupus Nephritis - drug therapy | Male | Tacrolimus - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Maintenance Chemotherapy - methods | Calcineurin - therapeutic use | Female | Immunosuppressive Agents - adverse effects | Azathioprine - adverse effects | Glucocorticoids - adverse effects | Index Medicus
Journal Article